Skip to content

Randomised trial, 1991

Does magnesium supplementation help premenstrual mood changes?

Yes, magnesium significantly improved mood-related PMS symptoms and overall PMS scores in women taking it during the premenstrual phase.

Moderate study design Thirty-two women aged 24 to 39 with confirmed PMS

What they did

Thirty-two women aged 24 to 39 with confirmed PMS participated in a double-blind, randomized study. After 2 months of baseline recording, women received either placebo or magnesium 360 mg three times daily for two cycles, then both groups received magnesium for two more cycles. Medication was given from day 15 of the cycle until menstrual flow began.

What they found

In the second month of treatment, magnesium significantly reduced both the total PMS score and the mood-related symptom cluster. Blood magnesium levels increased in white blood cells of women receiving magnesium. Pain was reduced in both treatment and placebo groups, suggesting a non-specific effect.

What it means for you

Taking magnesium in the premenstrual phase can improve mood symptoms of PMS. Some symptom reduction also occurred with placebo, suggesting expectations may play a role. The study was moderate-sized and well-designed.

32

women with confirmed PMS

360 mg

magnesium dose three times daily

24-39

age range in years

About the study

Original title
Oral magnesium successfully relieves premenstrual mood changes
Authors
Facchinetti F, Borella P, Sances G et al.
Journal
Obstetrics and gynecology
Year
1991
Study design
Randomised trial
Participants
32
What was tested
Magnesium pyrrolidone carboxylic acid 360 mg three times daily from day 15 of the cycle until menstrual flow versus placebo
Open access
Yes
Original abstract

Reduced magnesium (Mg) levels have been reported in women affected by premenstrual syndrome (PMS). To evaluate the effects of an oral Mg preparation on premenstrual symptoms, we studied, by a double-blind, randomized design, 32 women (24-39 years old) with PMS confirmed by the Moos Menstrual Distress Questionnaire. After 2 months of baseline recording, the subjects were randomly assigned to placebo or Mg for two cycles. In the next two cycles, both groups received Mg. Magnesium pyrrolidone carboxylic acid (360 mg Mg) or placebo was administered three times a day, from the 15th day of the menstrual cycle to the onset of menstrual flow. Blood samples for Mg measurement were drawn premenstrually, during the baseline period, and in the second and fourth months of treatment. The Menstrual Distress Questionnaire score of the cluster "pain" was significantly reduced during the second month in both groups, whereas Mg treatment significantly affected both the total Menstrual Distress Questionnaire score and the cluster "negative affect." In the second month, the women assigned to treatment showed a significant increase in Mg in lymphocytes and polymorphonuclear cells, whereas no changes were observed in plasma and erythrocytes. These data indicate that Mg supplementation could represent an effective treatment of premenstrual symptoms related to mood changes.

Reproduced under CC-BY.

Topics